Medindia
Advertisement

Immediate Treatments for Hepatitis C Virus can be Cost-Effective

by Bidita Debnath on March 19, 2015 at 12:17 AM
Font : A-A+

Immediate Treatments for Hepatitis C Virus can be Cost-Effective

New treatments for hepatitis C virus (HCV) may be highly effective but are very expensive that may compel doctors and patients to consider delaying treatment. However, a new study shows that immediate treatment of HCV-infected patients with minimal or no scarring can be cost-effective, especially when lower treatment costs are assumed.

Hepatitis C is a liver disease spread through infected blood; it can lead to issues like cirrhosis of the liver and liver cancer. The Center for Disease Control, USA, has estimated that there are 3.2 million people in the US suffering from chronic hepatitis C — many of whom may not even know they are infected. Several medications can help treat the disease.

Advertisement

"The devastating effects of hepatitis C continue to threaten the health of many Americans, with baby boomers at particular risk. This analysis of treatment available for hepatitis C describes specific scenarios when immediate or earlier treatment can be both cost-effective and increase quality of life," said Dr. John Ward, co-author of the Hepatology study and director of CDC's Division of Viral Hepatitis. This study was published online March 16 in Hepatology.

Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
World Alzheimer's Day 2021 - 'Know Dementia, Know Alzheimer's
'Hybrid Immunity' may Help Elude COVID-19 Pandemic
Stroop Effect
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Chicken Pox Hepatitis A Hepatitis B Shigellosis Vasculitis Silent Killer Diseases Liver Aplastic Anemia Hepatitis C Hepatitis 

Recommended Reading
UnitedHealth Suggests Gilead's Harvoni as Preferred Hepatitis C Treatment
UnitedHealth Group Inc, the largest U.S. health insurer, has mentioned Gilead Sciences Inc's ......
Mylan Soon to Distribute Hepatitis C Drugs in India
Mylan, US drug maker soon to distribute two drugs in India to treat liver diseases. Mylan ......
Drug for Hepatitis C to be Launched in India by Gilead Sciences
The pill could treat six genotypes of hepatitis C if approved by regulators and is a combination of ...
After Calls for New Drugs, Spain Vows Hepatitis C Action
New measures to fight hepatitis C has been promised by Spain's government Monday, following ......
Aplastic Anemia
Aplastic anemia (AA) is a term that refers to a condition where the body fails to produce enough blo...
Chicken Pox
Chicken pox is an acute and highly contagious viral infection caused by the varicella zoster virus....
Hepatitis A
Hepatitis A is the most benign of the hepatitis viruses and usually has no long term side effects. H...
Hepatitis B
Hepatitis B is inflammation of the liver due to infection with the hepatitis B virus....
Hepatitis C
Hepatitis C is a contagious viral disease affecting the liver that is caused by the hepatitis C ......
Shigellosis
Shigellosis or Bacillary Dysentery is a common cause of gastro-enteritis worldwide and can cause blo...
Vasculitis
Vasculitis is an inflammation of the blood vessels of the body that can affect people of all ages; i...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use